FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2073240841> ?p ?o ?g. }

• W2073240841 endingPage "206" @default.
• W2073240841 startingPage "202" @default.
• W2073240841 abstract "A paucity of information exists regarding medications to treat dystonia in children with cerebral palsy. This study sought to review the benefits and tolerability of trihexyphenidyl in children with cerebral palsy, treated for dystonia or sialorrhea or both in a pediatric tertiary care hospital, through a retrospective chart review. In total, 101 patients (61 boys and 40 girls) were evaluated. The mean age at drug initiation was 7 years and 10 months (range, 1-18 years). The mean initial dose was 0.095 mg/kg/day. The dose was increased by 10-20% no sooner than every 2 weeks. The mean maximum dose reached was 0.55 mg/kg/day. Ninety-three patients (91%) tolerated the medication well, with a mean duration of treatment of 3 years and 7 months. Side effects occurred in 69% of subjects, the majority in patients aged ≥7 years, and soon after treatment initiation. Sixty-four percent continued the treatment at study end. Ninety-seven patients reported benefits, including reduction of dystonia in upper (59.4%) and lower (37.6%) extremities, sialorrhea (60.4%), and speech issues (24.7%). The majority of patients tolerated trihexyphenidyl well on a schedule of gradual dose increases, and almost all demonstrated improvements in dystonia or sialorrhea or both. A paucity of information exists regarding medications to treat dystonia in children with cerebral palsy. This study sought to review the benefits and tolerability of trihexyphenidyl in children with cerebral palsy, treated for dystonia or sialorrhea or both in a pediatric tertiary care hospital, through a retrospective chart review. In total, 101 patients (61 boys and 40 girls) were evaluated. The mean age at drug initiation was 7 years and 10 months (range, 1-18 years). The mean initial dose was 0.095 mg/kg/day. The dose was increased by 10-20% no sooner than every 2 weeks. The mean maximum dose reached was 0.55 mg/kg/day. Ninety-three patients (91%) tolerated the medication well, with a mean duration of treatment of 3 years and 7 months. Side effects occurred in 69% of subjects, the majority in patients aged ≥7 years, and soon after treatment initiation. Sixty-four percent continued the treatment at study end. Ninety-seven patients reported benefits, including reduction of dystonia in upper (59.4%) and lower (37.6%) extremities, sialorrhea (60.4%), and speech issues (24.7%). The majority of patients tolerated trihexyphenidyl well on a schedule of gradual dose increases, and almost all demonstrated improvements in dystonia or sialorrhea or both." @default.
• W2073240841 created "2016-06-24" @default.
• W2073240841 creator A5004227153 @default.
• W2073240841 creator A5018107363 @default.
• W2073240841 creator A5035772699 @default.
• W2073240841 creator A5076632414 @default.
• W2073240841 date "2011-03-01" @default.
• W2073240841 modified "2023-10-18" @default.
• W2073240841 title "Use of Trihexyphenidyl in Children With Cerebral Palsy" @default.
• W2073240841 cites W1608815450 @default.
• W2073240841 cites W1989127514 @default.
• W2073240841 cites W1996679986 @default.
• W2073240841 cites W2000708211 @default.
• W2073240841 cites W2041557567 @default.
• W2073240841 cites W2086048769 @default.
• W2073240841 cites W2098311427 @default.
• W2073240841 cites W2101639093 @default.
• W2073240841 cites W2110269352 @default.
• W2073240841 cites W2112230186 @default.
• W2073240841 cites W2146651131 @default.
• W2073240841 cites W2157360623 @default.
• W2073240841 cites W2164608275 @default.
• W2073240841 cites W2167293566 @default.
• W2073240841 cites W2170099181 @default.
• W2073240841 cites W2414798147 @default.
• W2073240841 cites W2902195799 @default.
• W2073240841 doi "https://doi.org/10.1016/j.pediatrneurol.2010.09.008" @default.
• W2073240841 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21310336" @default.
• W2073240841 hasPublicationYear "2011" @default.
• W2073240841 type Work @default.
• W2073240841 sameAs 2073240841 @default.
• W2073240841 citedByCount "40" @default.
• W2073240841 countsByYear W20732408412012 @default.
• W2073240841 countsByYear W20732408412013 @default.
• W2073240841 countsByYear W20732408412014 @default.
• W2073240841 countsByYear W20732408412015 @default.
• W2073240841 countsByYear W20732408412016 @default.
• W2073240841 countsByYear W20732408412017 @default.
• W2073240841 countsByYear W20732408412018 @default.
• W2073240841 countsByYear W20732408412019 @default.
• W2073240841 countsByYear W20732408412020 @default.
• W2073240841 countsByYear W20732408412021 @default.
• W2073240841 countsByYear W20732408412022 @default.
• W2073240841 countsByYear W20732408412023 @default.
• W2073240841 crossrefType "journal-article" @default.
• W2073240841 hasAuthorship W2073240841A5004227153 @default.
• W2073240841 hasAuthorship W2073240841A5018107363 @default.
• W2073240841 hasAuthorship W2073240841A5035772699 @default.
• W2073240841 hasAuthorship W2073240841A5076632414 @default.
• W2073240841 hasConcept C118552586 @default.
• W2073240841 hasConcept C126322002 @default.
• W2073240841 hasConcept C141071460 @default.
• W2073240841 hasConcept C167135981 @default.
• W2073240841 hasConcept C1862650 @default.
• W2073240841 hasConcept C187212893 @default.
• W2073240841 hasConcept C197934379 @default.
• W2073240841 hasConcept C2776796639 @default.
• W2073240841 hasConcept C2778375690 @default.
• W2073240841 hasConcept C2778559928 @default.
• W2073240841 hasConcept C2779406339 @default.
• W2073240841 hasConcept C2779421357 @default.
• W2073240841 hasConcept C2909146933 @default.
• W2073240841 hasConcept C42219234 @default.
• W2073240841 hasConcept C71924100 @default.
• W2073240841 hasConceptScore W2073240841C118552586 @default.
• W2073240841 hasConceptScore W2073240841C126322002 @default.
• W2073240841 hasConceptScore W2073240841C141071460 @default.
• W2073240841 hasConceptScore W2073240841C167135981 @default.
• W2073240841 hasConceptScore W2073240841C1862650 @default.
• W2073240841 hasConceptScore W2073240841C187212893 @default.
• W2073240841 hasConceptScore W2073240841C197934379 @default.
• W2073240841 hasConceptScore W2073240841C2776796639 @default.
• W2073240841 hasConceptScore W2073240841C2778375690 @default.
• W2073240841 hasConceptScore W2073240841C2778559928 @default.
• W2073240841 hasConceptScore W2073240841C2779406339 @default.
• W2073240841 hasConceptScore W2073240841C2779421357 @default.
• W2073240841 hasConceptScore W2073240841C2909146933 @default.
• W2073240841 hasConceptScore W2073240841C42219234 @default.
• W2073240841 hasConceptScore W2073240841C71924100 @default.
• W2073240841 hasIssue "3" @default.
• W2073240841 hasLocation W20732408411 @default.
• W2073240841 hasLocation W20732408412 @default.
• W2073240841 hasOpenAccess W2073240841 @default.
• W2073240841 hasPrimaryLocation W20732408411 @default.
• W2073240841 hasRelatedWork W1971766183 @default.
• W2073240841 hasRelatedWork W2062864423 @default.
• W2073240841 hasRelatedWork W2073240841 @default.
• W2073240841 hasRelatedWork W2075102446 @default.
• W2073240841 hasRelatedWork W2138084578 @default.
• W2073240841 hasRelatedWork W2202751912 @default.
• W2073240841 hasRelatedWork W2387593096 @default.
• W2073240841 hasRelatedWork W2409513625 @default.
• W2073240841 hasRelatedWork W2912548033 @default.
• W2073240841 hasRelatedWork W4251617836 @default.
• W2073240841 hasVolume "44" @default.
• W2073240841 isParatext "false" @default.
• W2073240841 isRetracted "false" @default.
• W2073240841 magId "2073240841" @default.

• next